List of Tables
Table 1. Global Sustained and Controlled Release Formulations Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Sustained and Controlled Release Formulations Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Sustained and Controlled Release Formulations Market Competitive Situation by Manufacturers in 2024
Table 4. Global Sustained and Controlled Release Formulations Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Sustained and Controlled Release Formulations Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Sustained and Controlled Release Formulations Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Sustained and Controlled Release Formulations Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Sustained and Controlled Release Formulations Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Sustained and Controlled Release Formulations, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Sustained and Controlled Release Formulations, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Sustained and Controlled Release Formulations, Product Type & Application
Table 12. Global Key Manufacturers of Sustained and Controlled Release Formulations, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sustained and Controlled Release Formulations by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sustained and Controlled Release Formulations as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sustained and Controlled Release Formulations Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Sustained and Controlled Release Formulations Sales by Region (2020-2025) & (K Units)
Table 18. Global Sustained and Controlled Release Formulations Sales Market Share by Region (2020-2025)
Table 19. Global Sustained and Controlled Release Formulations Sales by Region (2026-2031) & (K Units)
Table 20. Global Sustained and Controlled Release Formulations Sales Market Share by Region (2026-2031)
Table 21. Global Sustained and Controlled Release Formulations Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Sustained and Controlled Release Formulations Revenue Market Share by Region (2020-2025)
Table 23. Global Sustained and Controlled Release Formulations Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Sustained and Controlled Release Formulations Revenue Market Share by Region (2026-2031)
Table 25. North America Sustained and Controlled Release Formulations Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Sustained and Controlled Release Formulations Sales by Country (2020-2025) & (K Units)
Table 27. North America Sustained and Controlled Release Formulations Sales by Country (2026-2031) & (K Units)
Table 28. North America Sustained and Controlled Release Formulations Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Sustained and Controlled Release Formulations Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Sustained and Controlled Release Formulations Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Sustained and Controlled Release Formulations Sales by Country (2020-2025) & (K Units)
Table 32. Europe Sustained and Controlled Release Formulations Sales by Country (2026-2031) & (K Units)
Table 33. Europe Sustained and Controlled Release Formulations Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Sustained and Controlled Release Formulations Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Sustained and Controlled Release Formulations Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Sustained and Controlled Release Formulations Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Sustained and Controlled Release Formulations Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Sustained and Controlled Release Formulations Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Sustained and Controlled Release Formulations Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Sustained and Controlled Release Formulations Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Sustained and Controlled Release Formulations Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Sustained and Controlled Release Formulations Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Sustained and Controlled Release Formulations Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Sustained and Controlled Release Formulations Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Sustained and Controlled Release Formulations Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Sustained and Controlled Release Formulations Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Sustained and Controlled Release Formulations Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Sustained and Controlled Release Formulations Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Sustained and Controlled Release Formulations Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Sustained and Controlled Release Formulations Sales (K Units) by Type (2020-2025)
Table 51. Global Sustained and Controlled Release Formulations Sales (K Units) by Type (2026-2031)
Table 52. Global Sustained and Controlled Release Formulations Sales Market Share by Type (2020-2025)
Table 53. Global Sustained and Controlled Release Formulations Sales Market Share by Type (2026-2031)
Table 54. Global Sustained and Controlled Release Formulations Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Sustained and Controlled Release Formulations Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Sustained and Controlled Release Formulations Revenue Market Share by Type (2020-2025)
Table 57. Global Sustained and Controlled Release Formulations Revenue Market Share by Type (2026-2031)
Table 58. Global Sustained and Controlled Release Formulations Price (US$/Unit) by Type (2020-2025)
Table 59. Global Sustained and Controlled Release Formulations Price (US$/Unit) by Type (2026-2031)
Table 60. Global Sustained and Controlled Release Formulations Sales (K Units) by Application (2020-2025)
Table 61. Global Sustained and Controlled Release Formulations Sales (K Units) by Application (2026-2031)
Table 62. Global Sustained and Controlled Release Formulations Sales Market Share by Application (2020-2025)
Table 63. Global Sustained and Controlled Release Formulations Sales Market Share by Application (2026-2031)
Table 64. Global Sustained and Controlled Release Formulations Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Sustained and Controlled Release Formulations Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Sustained and Controlled Release Formulations Revenue Market Share by Application (2020-2025)
Table 67. Global Sustained and Controlled Release Formulations Revenue Market Share by Application (2026-2031)
Table 68. Global Sustained and Controlled Release Formulations Price (US$/Unit) by Application (2020-2025)
Table 69. Global Sustained and Controlled Release Formulations Price (US$/Unit) by Application (2026-2031)
Table 70. Humanwell Healthcare Co.,Ltd. Company Information
Table 71. Humanwell Healthcare Co.,Ltd. Description and Business Overview
Table 72. Humanwell Healthcare Co.,Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Humanwell Healthcare Co.,Ltd. Sustained and Controlled Release Formulations Product
Table 74. Humanwell Healthcare Co.,Ltd. Recent Developments/Updates
Table 75. Nanjing Yiheng Pharmaceutical Co., Ltd. Company Information
Table 76. Nanjing Yiheng Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. Nanjing Yiheng Pharmaceutical Co., Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Nanjing Yiheng Pharmaceutical Co., Ltd. Sustained and Controlled Release Formulations Product
Table 79. Nanjing Yiheng Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
Table 81. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Description and Business Overview
Table 82. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Sustained and Controlled Release Formulations Product
Table 84. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments/Updates
Table 85. Qilu Pharmaceutical Co Ltd Company Information
Table 86. Qilu Pharmaceutical Co Ltd Description and Business Overview
Table 87. Qilu Pharmaceutical Co Ltd Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Qilu Pharmaceutical Co Ltd Sustained and Controlled Release Formulations Product
Table 89. Qilu Pharmaceutical Co Ltd Recent Developments/Updates
Table 90. Shanghai Pharmaceuticals Holding Co.,Ltd. Company Information
Table 91. Shanghai Pharmaceuticals Holding Co.,Ltd. Description and Business Overview
Table 92. Shanghai Pharmaceuticals Holding Co.,Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Shanghai Pharmaceuticals Holding Co.,Ltd. Sustained and Controlled Release Formulations Product
Table 94. Shanghai Pharmaceuticals Holding Co.,Ltd. Recent Developments/Updates
Table 95. Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
Table 96. Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Business Overview
Table 97. Yangtze River Pharmaceutical (Group) Co., Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Yangtze River Pharmaceutical (Group) Co., Ltd. Sustained and Controlled Release Formulations Product
Table 99. Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
Table 100. PKU HealthCare Corp.,Ltd. Company Information
Table 101. PKU HealthCare Corp.,Ltd. Description and Business Overview
Table 102. PKU HealthCare Corp.,Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. PKU HealthCare Corp.,Ltd. Sustained and Controlled Release Formulations Product
Table 104. PKU HealthCare Corp.,Ltd. Recent Developments/Updates
Table 105. Overseas Pharmaceuticals, Ltd. Company Information
Table 106. Overseas Pharmaceuticals, Ltd. Description and Business Overview
Table 107. Overseas Pharmaceuticals, Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Overseas Pharmaceuticals, Ltd. Sustained and Controlled Release Formulations Product
Table 109. Overseas Pharmaceuticals, Ltd. Recent Developments/Updates
Table 110. Novast Laboratories (China), LTD. Company Information
Table 111. Novast Laboratories (China), LTD. Description and Business Overview
Table 112. Novast Laboratories (China), LTD. Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Novast Laboratories (China), LTD. Sustained and Controlled Release Formulations Product
Table 114. Novast Laboratories (China), LTD. Recent Developments/Updates
Table 115. Catalent Company Information
Table 116. Catalent Description and Business Overview
Table 117. Catalent Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Catalent Sustained and Controlled Release Formulations Product
Table 119. Catalent Recent Developments/Updates
Table 120. AstraZeneca Plc Company Information
Table 121. AstraZeneca Plc Description and Business Overview
Table 122. AstraZeneca Plc Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. AstraZeneca Plc Sustained and Controlled Release Formulations Product
Table 124. AstraZeneca Plc Recent Developments/Updates
Table 125. Oakwood Labs Company Information
Table 126. Oakwood Labs Description and Business Overview
Table 127. Oakwood Labs Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Oakwood Labs Sustained and Controlled Release Formulations Product
Table 129. Oakwood Labs Recent Developments/Updates
Table 130. Ascendia Pharma Company Information
Table 131. Ascendia Pharma Description and Business Overview
Table 132. Ascendia Pharma Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Ascendia Pharma Sustained and Controlled Release Formulations Product
Table 134. Ascendia Pharma Recent Developments/Updates
Table 135. Colorcon Company Information
Table 136. Colorcon Description and Business Overview
Table 137. Colorcon Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Colorcon Sustained and Controlled Release Formulations Product
Table 139. Colorcon Recent Developments/Updates
Table 140. Pfizer Inc. Company Information
Table 141. Pfizer Inc. Description and Business Overview
Table 142. Pfizer Inc. Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Pfizer Inc. Sustained and Controlled Release Formulations Product
Table 144. Pfizer Inc. Recent Developments/Updates
Table 145. Mylan Company Information
Table 146. Mylan Description and Business Overview
Table 147. Mylan Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Mylan Sustained and Controlled Release Formulations Product
Table 149. Mylan Recent Developments/Updates
Table 150. Sandoz Company Information
Table 151. Sandoz Description and Business Overview
Table 152. Sandoz Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Sandoz Sustained and Controlled Release Formulations Product
Table 154. Sandoz Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Sustained and Controlled Release Formulations Distributors List
Table 158. Sustained and Controlled Release Formulations Customers List
Table 159. Sustained and Controlled Release Formulations Market Trends
Table 160. Sustained and Controlled Release Formulations Market Drivers
Table 161. Sustained and Controlled Release Formulations Market Challenges
Table 162. Sustained and Controlled Release Formulations Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Sustained and Controlled Release Formulations
Figure 2. Global Sustained and Controlled Release Formulations Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sustained and Controlled Release Formulations Market Share by Type: 2024 & 2031
Figure 4. Generic Drug Product Picture
Figure 5. Original Drug Product Picture
Figure 6. Global Sustained and Controlled Release Formulations Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Sustained and Controlled Release Formulations Market Share by Application: 2024 & 2031
Figure 8. Cardiovascular System Drugs
Figure 9. Nervous System Drugs
Figure 10. Digestive System and Metabolism
Figure 11. Other
Figure 12. Global Sustained and Controlled Release Formulations Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Sustained and Controlled Release Formulations Market Size (2020-2031) & (US$ Million)
Figure 14. Global Sustained and Controlled Release Formulations Sales (2020-2031) & (K Units)
Figure 15. Global Sustained and Controlled Release Formulations Average Price (US$/Unit) & (2020-2031)
Figure 16. Sustained and Controlled Release Formulations Report Years Considered
Figure 17. Sustained and Controlled Release Formulations Sales Share by Manufacturers in 2024
Figure 18. Global Sustained and Controlled Release Formulations Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Sustained and Controlled Release Formulations Players: Market Share by Revenue in Sustained and Controlled Release Formulations in 2024
Figure 20. Sustained and Controlled Release Formulations Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Sustained and Controlled Release Formulations Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Sustained and Controlled Release Formulations Sales Market Share by Country (2020-2031)
Figure 23. North America Sustained and Controlled Release Formulations Revenue Market Share by Country (2020-2031)
Figure 24. United States Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Sustained and Controlled Release Formulations Sales Market Share by Country (2020-2031)
Figure 27. Europe Sustained and Controlled Release Formulations Revenue Market Share by Country (2020-2031)
Figure 28. Germany Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Sustained and Controlled Release Formulations Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Sustained and Controlled Release Formulations Revenue Market Share by Region (2020-2031)
Figure 35. China Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Sustained and Controlled Release Formulations Sales Market Share by Country (2020-2031)
Figure 43. Latin America Sustained and Controlled Release Formulations Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Sustained and Controlled Release Formulations Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Sustained and Controlled Release Formulations Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Sustained and Controlled Release Formulations Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Sustained and Controlled Release Formulations by Type (2020-2031)
Figure 53. Global Revenue Market Share of Sustained and Controlled Release Formulations by Type (2020-2031)
Figure 54. Global Sustained and Controlled Release Formulations Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Sustained and Controlled Release Formulations by Application (2020-2031)
Figure 56. Global Revenue Market Share of Sustained and Controlled Release Formulations by Application (2020-2031)
Figure 57. Global Sustained and Controlled Release Formulations Price (US$/Unit) by Application (2020-2031)
Figure 58. Sustained and Controlled Release Formulations Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
